2024 International Headache Academy

The International Headache Academy is designed to inspire a long-term commitment to headache medicine in young neurologists and research scientists via an educational program focused on clinical and research aspects of the field.

The American Headache Society is dedicated to mentoring future leaders in headache medicine through both outreach and continued education.

Program Details

The Tenth Annual IHA will be held January 25-27, 2024 at the UCLA Meyer and Renee Luskin Conference Center in Los Angeles, CA.

Participants will be introduced to multiple opportunities in the field of Headache Medicine, with the world’s leading experts providing hands-on instruction in the pathophysiology, diagnosis, treatment, and education of patients with migraine, cluster headache, and related primary headache disorders, as well as practical education in clinical trial methodology, biostatistics, and the preparation and publication of study results.

The program features formal conference sessions as well as networking opportunities to meet colleagues and headache medicine experts. Small research grants may also be available through submission of an optional research proposal.

Health and Safety Policy

The AHS actively monitors the health and safety guidance from the Centers for Disease Control as well as state and local health departments. We want attendees to enjoy a safe environment at all AHS meetings. While the AHS continues to recommend people are up to date on COVID-19 vaccination, attendees of AHS meetings are not required to be vaccinated or verify vaccination status. In addition, masks are optional for AHS meetings and prior antigen testing is not required. We will continue to follow best practices recommended by the Centers for Disease Control and Prevention and abide by any legal mandates and recommendations from government officials in the location of any AHS meeting. These protocols and information are subject to change.

Please note, even with safeguards and the AHS’s overarching commitment to attendee wellness, there remains a risk of contracting COVID-19.